相关实验视频
Updated: May 12, 2026

11:36
Glycan Node Analysis: A Bottom-up Approach to Glycomics
Published on: May 22, 2016
10.5K
患有口腔状细胞癌的患者血清中的疾病特异性N- 糖
Tiialotta Tohmola1,2, Sakari Joenväärä3,4, Amy Dickinson5,6
1Transplantation Laboratory, Haartman Institute and Helsinki University Hospital, University of Helsinki, PL 21 (Haartmaninkatu 3), Helsinki, 00014, Finland. tiialotta.tohmola@helsinki.fi.
Scientific reports
|September 1, 2025
概括
在口腔状细胞癌 (OSCC) 中,血清N- 糖化模式呈现出明显的变化. 这些在OSCC中特别明显的糖形式可以作为早期癌症检测的新型疾病特异性生物标志物.
科学领域:
- 蛋白质组学
- 葡萄糖化合物
- 癌症学
背景情况:
- 与HPV驱动的口腔癌不同,口腔癌的发病率上升没有明确原因.
- 口腔癌的晚期诊断会对患者的预后产生负面影响.
- 通过血液生物标志物进行早期检测对于改善患者的治疗结果至关重要.
研究的目的:
- 在口腔状细胞癌 (OSCC) 患者和健康对照者之间研究血清蛋白N-糖化量的定量和定性差异.
- 为了确定早期检测口腔癌的潜在N-糖化生物标志物.
主要方法:
- 使用基于无标签质谱的蛋白质组学和N-糖组学.
- 分析了OSCC患者和健康对照者的血清样本.
- 对比了定量和定性N- 糖化特征.
主要成果:
- 从7种丰富的血清蛋白中鉴定出25种N- 糖.
- 虽然总体蛋白质表达的变化很小 (≤2倍),但特定的葡萄糖形式呈现出显著的变化 (7~33倍的差异).
- 在OSCC中观察到的N-糖化模式与口腔癌的不同,表明疾病特异性.
结论:
- 改变的血清蛋白N-糖化模式是口腔状细胞癌的特征.
- 特定的N-glycoform显示为口腔癌的敏感和特定生物标志物.
- 糖化分析为开发针对癌症的新型诊断工具提供了一个有前途的途径.
相关概念视频
Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pathophysiology of Diabetes
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

